Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Pfizer 14.451, BioNTech 0.114.
Pfizer vs BioNTech Net Worth and Market Cap
Pfizer (PFE) and BioNTech (BNTX) are peers in Vaccines. Pfizer reported revenue of $14.5B as of Q1 2026, compared with $114M for BioNTech. Pfizer leads on revenue.
Pfizer's gross margin is 67.3% versus 8.1% for BioNTech. Pfizer's net margin is 18.6% versus -777.3% for BioNTech.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, BioNTech.| Metric | Pfizer | BioNTech |
|---|---|---|
| Market Cap | - | - |
| Revenue | $14.45B | $114.00M |
| Cost of Revenue | $4.73B | $105.00M |
| Gross Profit | $9.72B | $9.00M |
| Operating Income | $4.03B | $-1.02B |
| Net Income | $2.69B | $-886.00M |
| R&D Expense | $2.63B | $595.00M |
| Earnings Per Share | $0.47 | -$3.5 |
| Gross Margin | 67.3% | 8.1% |
| Operating Margin | 27.9% | -897.8% |
| Net Profit Margin | 18.6% | -777.3% |
| Free Cash Flow | $2.18B | $-48.00M |
| Cumulative Free Cash Flow | $356.40B | $19.56B |
| Operating Cash Flow | $2.62B | $12.00M |
| Cash & Equivalents | $1.70B | $10.52B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.